Lyophilization (ANVISA APPROVED) / Hormonal Section /Dydrogesterone (PIC/S APPROVED)

  • Lyophilization (ANVISA APPROVED) / Hormonal Section /Dydrogesterone (PIC/S APPROVED) 1
  • Lyophilization (ANVISA APPROVED) / Hormonal Section /Dydrogesterone (PIC/S APPROVED) 2
Product Description

Lyophilized vials

Read more Show less

Nabiqasim Pharma Group

  • Country/Region:
    Pakistan
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less

Nabiqasim Pharma Group

  • Country/Region:
    Pakistan
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile

More Products from Nabiqasim Pharma Group (2)

  • Cardiovascular

    Product Cardiovascular

    Nabiqasim offers a wide range of Cardiovascular products in combination and single ingredient including APIXABAN; RIVIROXABAN; SACUBITRIL+VALSARTAN; ROSUVASTATIN+EZETIMIBE and many others. 
  • Hypoglycemics

    Product Hypoglycemics

    Nabiqasim offers a wide range of Hypoglycemic products including DAPAGLIFLOZIN+METFORMIN HYDROCHLORIDE EXTENDED RELEASE; EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE;  EMPAGLIFLOZIN+LINAGLIPTIN+METFORMIN HYDROCHLORIDE EXTENDED RELEASE and many others

Nabiqasim Pharma Group resources (1)

  • PIC/S and ANVISA Approval

    News PIC/S and ANVISA Approval

    Nabiqasim Pharma proudly announces the successful accreditation of its Injectable & Lyophilized Section by ANVISA and Hormonal Solid Dosage Manufacturing Section by PIC/S. 
    10 Oct 2025